0001104659-24-039129.txt : 20240326 0001104659-24-039129.hdr.sgml : 20240326 20240326181133 ACCESSION NUMBER: 0001104659-24-039129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240326 DATE AS OF CHANGE: 20240326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacobs John C CENTRAL INDEX KEY: 0001820836 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 24785155 MAIL ADDRESS: STREET 1: 630 W. GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 QUINCE ORCHARD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 700 QUINCE ORCHARD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 tm249879-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-01 0 0001000694 NOVAVAX INC NVAX 0001820836 Jacobs John C C/O NOVAVAX, INC. 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 1 1 0 0 President and CEO 0 Stock Option (Right to Buy) 5.39 2024-03-01 4 A 0 500000 0.00 A 2025-03-01 2034-03-01 Common Stock 500000 500000 D Restricted Stock Units 2024-03-01 4 A 0 250000 0.00 A Common Stock 250000 250000 D Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on the first anniversary of the March 1, 2024 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock. One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 Grant Date, in each case subject to continued employment through such vesting date. /s/ Mark J. Casey, Attorney-in-Fact 2024-03-26